REPL — Replek AD Skopje Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Replek AD Skopje, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	—	IFRS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,251	1,220	1,252	1,587	1,948
Cost of Revenue
Gross Profit	570	579	591	811	977
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,066	1,059	1,147	1,280	1,671
Operating Profit	185	161	105	308	277
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	183	154	97.9	295	258
Provision for Income Taxes
Net Income After Taxes	164	135	81.9	281	224
Net Income Before Extraordinary Items
Net Income	164	135	81.9	281	224
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	164	135	81.9	281	224
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	6,457	5,200	3,998	21,105	9,720
Dividends per Share